Livent (LTHM) Stock Rating Lowered by Citigroup

Share on StockTwits

Citigroup downgraded shares of Livent (NASDAQ:LTHM) from a buy rating to a neutral rating in a report released on Monday morning, BenzingaRatingsTable reports. They currently have $13.00 price objective on the stock, down from their prior price objective of $15.00.

A number of other research firms also recently weighed in on LTHM. Loop Capital set a $22.00 target price on Livent and gave the stock a buy rating in a research report on Monday, December 17th. Credit Suisse Group set a $20.00 target price on Livent and gave the stock a buy rating in a research report on Friday, January 4th. Nomura downgraded Livent from a buy rating to a neutral rating in a research report on Tuesday, January 15th. Gabelli began coverage on Livent in a research report on Wednesday, February 27th. They issued a buy rating and a $21.00 target price for the company. Finally, Zacks Investment Research upgraded Livent from a hold rating to a strong-buy rating and set a $15.00 target price for the company in a research report on Friday, December 28th. One research analyst has rated the stock with a sell rating, four have given a hold rating and ten have given a buy rating to the stock. The stock currently has a consensus rating of Buy and an average price target of $18.71.

Shares of NASDAQ LTHM opened at $12.20 on Monday. Livent has a 12-month low of $11.55 and a 12-month high of $19.90.

Livent (NASDAQ:LTHM) last released its earnings results on Monday, February 11th. The company reported $0.23 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.23. The firm had revenue of $119.80 million during the quarter, compared to analyst estimates of $124.70 million.

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Athena Capital Advisors LLC bought a new position in shares of Livent in the fourth quarter valued at $28,000. PNC Financial Services Group Inc. bought a new position in shares of Livent in the fourth quarter valued at $31,000. Glassman Wealth Services bought a new position in shares of Livent in the fourth quarter valued at $33,000. Kwmg LLC bought a new position in shares of Livent in the fourth quarter valued at $63,000. Finally, Citigroup Inc. bought a new position in shares of Livent in the fourth quarter valued at $85,000.

Livent Company Profile

Livent Corporation manufactures and sells performance lithium compounds that are used primarily in energy storage, specialty polymers, and chemical synthesis application. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and supplies butyllithium, which is used as a synthesizer in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in the production of lightweight materials for aerospace applications and non-rechargeable batteries.

Further Reading: Net Asset Value

Analyst Recommendations for Livent (NASDAQ:LTHM)

Receive News & Ratings for Livent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livent and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Tenaris SA  Expected to Announce Earnings of $0.35 Per Share
Tenaris SA Expected to Announce Earnings of $0.35 Per Share
Helleniccoin Price Down 11.7% This Week
Helleniccoin Price Down 11.7% This Week
Ultrapar Participacoes  Share Price Crosses Above 50-Day Moving Average of $5.31
Ultrapar Participacoes Share Price Crosses Above 50-Day Moving Average of $5.31
Scorum Coins  Price Up 97.1% This Week
Scorum Coins Price Up 97.1% This Week
Cellectis  Raised to Buy at Zacks Investment Research
Cellectis Raised to Buy at Zacks Investment Research
ZCore   Trading 5.7% Lower  Over Last Week
ZCore Trading 5.7% Lower Over Last Week


 
© 2006-2019 Zolmax.